跳至主要内容
临床试验/NCT02479581
NCT02479581已完成2 期

The Safety and Efficacy of the Enhanced Recovery After Surgery(ERAS) Applied on Cardiac Surgery With Cardiopulmonary Bypass: a Single Center, Randomized, Controlled Clinical Study

Xiangya Hospital of Central South University1 个研究点 分布在 1 个国家目标入组 226 人开始时间: 2015年7月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
226
试验地点
1
主要终点
The length of hospital stay

研究概览

简要总结

This study evaluates the enhanced recovery after surgery (ERAS) concept over conventional postoperative care in patients with heart valve disease undergoing cardiac surgery with cardiopulmonary bypass. Half of participants will adherence to the ERAS, while the other half will under the conventional postoperative care.

详细描述

Enhanced recovery after surgery (ERAS) or fast-track surgery is a perioperative and postoperative care concept initiated in the early 1990s aiming to reduce the length of hospital stays following elective abdominal surgery. The success of ERAS depends highly on multidisciplinary teamwork and patient compliance.

This study intends to compare the Enhanced Recovery After Surgery (ERAS) concept applied to patients with heart valve disease undergoing cardiac surgery with cardiopulmonary bypass under traditional perioperative management of patients, committed to reducing patient's physical and psychological stress by surgical trauma, achieve the purpose of fast recovery, in order to establish an effective perioperative management during cardiopulmonary bypass surgery, improve patients' satisfaction and to accelerate postoperative rehabilitation safely.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Heart function grade II - III (Using the cardiac function classification method formulated by American Heart Disease Institute)
  • The in - hospital was treated with extracorporeal circulation operation and general anesthesia.
  • Had a good cognition, and signed the informed consent.
  • Aged between 18 and
  • The age, clinical examination and other generally situation of the two groups of patients had no statistical significance.

排除标准

  • Combined with other blood coagulation dysfunction, serious brain, liver and kidney dysfunction, endocrine system diseases and serious infectious disease.
  • Patients with severe mental disorders cannot cooperate with the treatment.
  • Emergency operation
  • Have taboo of Echocardiography and pulmonary catheterization by echocardiography.
  • Patients have been fitted with a pacemaker.
  • Allergic to erythropoietin.
  • Suspected or had alcohol, drug abuse history.
  • Spinal deformity or paravertebral lesions.

结局指标

主要结局

The length of hospital stay

时间窗: From pre-surgery to discharge, up to 8 weeks

The postoperative hospital time

时间窗: From pre-surgery to discharge, up to 4 weeks

The time of readiness to discharge

时间窗: From pre-surgery to discharge, up to 4 weeks

Length of ICU stay

时间窗: From entering the ICU to roll out, up to 4 weeks

Hospitalization cost

时间窗: When the patient is discharged

次要结局

  • C-reactive protein(baseline and 5 days after operation)
  • Serum Creatinine(baseline and 5 days after operation)
  • Postoperative tracheal tube time(From the end of surgery to the removal of tracheal tube, up to 4 weeks)
  • Time to first bowel movement(From the end of surgery to first exhaust, up to 2 weeks)
  • Hemoglobin(baseline and 5 days after operation)
  • Troponin I(baseline and 5 days after operation)
  • Perioperative major adverse events(From pre-surgery to discharge, up to 4 weeks)
  • Procalcitonin(baseline and 5 days after operation)
  • Duration of mechanical ventilation after surgery(From the end of surgery to the recovery of spontaneous breathing, up to 4 weeks)
  • Postoperative time to first exhaust(From the end of surgery to first exhaust, up to 2 weeks)
  • Erythrocyte Sedimentation Rate(baseline and 5 days after operation)
  • Vasoactive drugs Support Hours(From the start of drugs to stop them, up to 4 weeks)
  • N-terminal B-type natriuretic peptide(NT-proBNP)(baseline and 5 days after operation)

研究者

发起方
Xiangya Hospital of Central South University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

The Safety and Efficacy of the Enhanced Recovery... | 临床试验